Breast CancerNCT06203197
The Effect of Mobile-Based Care and Monitoring on Lymphatic Edema Management and Quality of Life in Breast Surgery
A study testing Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS) in people with Breast Cancer, run by Sanko University at 1 site in Turkey (Türkiye).
Trial summary
There is a lack of synthesized evidence focusing on the design and development of mobile applications targeting the care of patients with breast cancer. This gap will impede understanding of care through mobile applications and hinder digital health intervention strategies that support these patients. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Breast Cancer
- What is being tested?
- Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Mar 2024to 30 Aug 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 18 years and over,
- Able to understand and speak Turkish,
- It is decided to undergo breast-conserving surgery or lymph node dissection,
- Using any of the social media applications (facebook, whatsapp, instagram)
Who cannot join
- Having another health problem (amputation, visible scar, visible physical disability, etc.) that may affect body image
- Those with speech, hearing and vision problems
- Having a psychiatric diagnosis
- Having a disease that restricts the movement of the upper extremity (rheumatological diseases, fracture, health problem that will cause joint restriction, amputation, etc.).
- Never used the application
- Study termination criteria;
- Discontinuation of communication with the patient before the data collection stages are completed
- Leaving work voluntarily
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Mobile-Based Care and Monitoring on Lymphatic Edema Management and Quality of Life in Patients Undergoing Breast Surgery
There is a lack of synthesized evidence focusing on the design and development of mobile applications targeting the care of patients with breast cancer. This gap will impede understanding of care through mobile applications and hinder digital health intervention strategies that support these patients. Considering the increasing needs of breast cancer patients, the magnitude of care burden, and the widespread use of mobile applications, increased studies are needed to improve care in this population. For this purpose, the mobile application to be developed in the project will include information that patients will need in the perioperative period, preoperative training, exercises to be done in the postoperative period, symptom management, nutrition and lifestyle content. Thus, it is thought that the mobile application will contribute to consultancy and care on issues such as patients' quality of life and symptom management.
Read the detailed description
Type of study: This study was planned as a randomized controlled intervention study to determine the effect of mobile-based care and monitoring on lymphedema management and quality of life in patients undergoing breast surgery.
Place and time of the research: It will be conducted at SANKO University Hospital General Surgery Service, after obtaining the permission of the ethics committee and the institution.
Research Population and sample of the research: Sample calculation In the doctoral thesis titled "The Effect of Mobile-Based Care Support Application on Symptom Management and Quality of Life of Patients Undergoing Breast Cancer Surgery", taking into account the last measurement quality of life score averages of the patients in the experimental and control groups, alpha = 0.05 and power = 0.80. When the calculation was made, the minimum sample size per group was found to be 18. It is recommended to have a minimum of 30 people per group. Randomization will be done using the minimization method.
Randomization:
- Number of radiotherapy sessions: 25-30
- Area where radiotherapy is applied: breast, lymph nodes, clavicle
- There is / is not lymph node metastasis
- Type of lymph node intervention taken: sentinal, axillary
- Number of lymph nodes removed: 10-20, 21-30, 30 and above
- BMI: 18-30, 30 and above
- Reconstruction plan: yes/no
- Surgery type: breast conservation, lymph node resection.
Application Process:
- Patients who meet the inclusion criteria for the study will be included in the control and intervention groups using the face-to-face interview method. The purpose of the research will be explained to the patients at the first pre-operative meeting in the general surgery service of the mentioned hospital, and an informed consent form and an Introductory Characteristics Questionnaire will be applied. Patients will be evaluated and assigned to groups according to randomization criteria.
Patients in the control group after surgery;
- Wound evaluation form every two weeks in the first two months,
- Monthly Arm Circumference Measurement Form for six months, Lymphatic Edema Findings Evaluation Form
- The Body Image and Sexual Adjustment Scale and Breast Cancer (FACT-B) quality of life scale (FACT-B) will be administered twice, in the first week and at the end of the 6-month period after the surgery.
Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS)) developed within the scope of the research after the surgery.
- Wound evaluation form every two weeks in the first two months,
- Arm Circumference Measurement Form and Lymphatic Discharge Findings Evaluation Form once a month for six months
- The Body Image and Sexual Adjustment Scale and the Functional Assessment Scale in Cancer Treatment (FACT-B) will be administered twice, in the first week and at the end of the 6-month period after the surgery
Since it is thought that the surgeon who performs the surgery is effective in the development of lymphedema, only Prof. Dr. Göktürk Maralcan's patients will be included.
M-MEKKBİS: The content of the application will include a video explaining the use of the application, information about the pre- and post-operative (short and long) period, scales and forms, and ask the specialist sections. Pre-application will be made after the mobile application is ready. A phone number, username and password will be created for patients who will use the mobile application.
Research Inclusion and Exclusion Criteria Acceptance criteria for the study;
- 18 years and over,
- Able to understand and speak Turkish,
- It is decided to undergo breast-conserving surgery or lymph node dissection,
- Using any of the social media applications (facebook, whatsapp, instagram)
Exclusion criteria from the study;
- Having another health problem (amputation, visible scar, visible physical disability, etc.) that may affect body image
- Those with speech, hearing and vision problems
- Having a psychiatric diagnosis
- Having a disease that restricts the movement of the upper extremity (rheumatological diseases, fracture, health problem that will cause joint restriction, amputation, etc.).
- Never used the application
Study termination criteria;
- Discontinuation of communication with the patient before the data collection stages are completed
- Leaving work voluntarily Data collection tools
- Informed Volunteer Consent Form
- Promotional Features Questionnaire
- Wound Site Evaluation Form
- Findings Regarding Lymphatic Edema Evaluation Form
- Body Image and Sexual Adjustment Scale
- Functional Assessment Scale in Cancer Treatment (FACT-B)
- Application Evaluation FormDescriptive Characteristics Questionnaire: This form, prepared by the researcher by scanning the relevant literature, contains 15 questions that will determine the sociodemographic characteristics of the patients and information about the surgery period.
Wound Site Evaluation Form: The Wound Site Evaluation Form was created by the researcher. In the form, the amount, color, density and odor of the exudate, the condition of the wound bed, the temperature of the wound, signs of infection and the duration of the drain are evaluated.
Lymph Edema Findings Evaluation Form: This form was created by the researcher by scanning the relevant literature to evaluate lymph edema findings. The form will evaluate whether there is swelling, tenderness, pain, stiffness, tension, numbness, burning, tingling, seroma, redness, blistering, warmth and limitation in wrist movements in the affected arm, which may have signs of lymphedema.
Body Image and Sexual Adjustment Scale: . The scale, which evaluates sexual adjustment and body image as two separate scales, has 14 items. It can be used as two different scales for women of all ages diagnosed with breast cancer. There is no total score for both scales, and sexual adjustment is evaluated through body image scores. Low mean scores indicate that patients are negatively (badly) affected.
Functional Assessment Scale in Cancer Treatment (FACT-B):
This scale was developed by the "Center on Outcomes, Research, and Education (CORE)" in the USA to determine the quality of life in cancer patients. The Functional Assessment Scale in Cancer Treatment (FACT) has been translated into 52 different languages and has scales for different types of cancer. Functional Assessment in Cancer Treatment-Breast Cancer (FACT-B) quality of life scale is a scale adapted to Turkish by the center that aims to measure the quality of life in breast cancer. Permission to use the scale was received by this center. The scale consists of five sub-dimensions and 36 items. Sub-dimensions; It includes physical (7 items), social/family (7 items), emotional (6 items) and functional well-being (7 items) and breast cancer (9 items). Responses are in five-point Likert type and all item scores are summed as "(0) not at all, (1) very little, (2) a little, (3) quite a bit and (4) very much". In calculating the scale score, negative responses are subtracted from four and included in the scoring, while positive statements are added to the scoring. All of the questions in the physical state sub-dimension and questions 1, 3, 4, 5 and 6 in the emotional state sub-dimension contain negative expressions. The total score of the scale varies between 0-144. The total score of the scale is evaluated in relation to the high quality of life.
Application Evaluation Form: M-MEKKBİS evaluation form was created by the researcher for breast cancer patients to evaluate the application. There are 6 questions in the M-MEKKBİS evaluation form.
Evaluation of data: In the analysis of data, mean ± std is used as descriptive statistics. deviation values will be given. Categorical variables will be defined as number (n) and percentage (%). Student-t test will be used to compare numerical data in 2 groups. Spearman rank correlation coefficient will be used to test the relationships between ordinal variables, and Chi square test and Fisher's exact Chi square test will be used to test the relationships between categorical variables. Analyzes will be performed in the Statistical Package for the Social Sciences (SPSS) 25.0 package program.
- Conditions
- Breast Cancer
- Being tested
- Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS)
- Keywords
- breast cancer, post surgical nursing, life quality
- Medical subject headings
- Breast Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS)Other
intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS).
| Study group | Role | What they receive |
|---|---|---|
| control | No intervention | Patients in the control group will receive routine clinical care after surgery. |
| intervention | Experimental | Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS)) developed within the scope of the research after the surgery. Receives: Other: Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Functional Assessment Scale in Cancer Treatment (FACT-B):
This scale was developed by the "Center on Outcomes, Research, and Education (CORE)" in the USA to determine the quality of life in cancer patients. The Functional Assessment Scale in Cancer Treatment (FACT) has been translated into 52 different languages and has scales for different types of cancer. Functional Assessment in Cancer Treatment-Breast Cancer (FACT-B) quality of life scale is a scale adapted to Turkish by the center that aims to measure the quality of life in breast cancer. Permission to use the scale was received by this center . All of the questions in the physical state sub-dimension and questions 1, 3, 4, 5 and 6 in the emotional state sub-dimension contain negative expressions. The total score of the scale varies between 0-144. The total score of the scale is evaluated in relation to the high quality of life.
Measured: six month
Secondary outcomes (3)
Body Image and Sexual Adjustment Scale
The sexual adjustment and body image scale was developed by Dalton et al. in 2009, and its validity and reliability in our country were confirmed by Erol Ursavaş and Karayurt in 2016. The scale, which evaluates sexual adjustment and body image as two separate scales, has 14 items. It can be used as two different scales for women of all ages diagnosed with breast cancer. There is no total score for both scales, and sexual adjustment is evaluated through body image scores. Low mean scores indicate that patients are negatively (badly) affected.
Measured: six month
Lymph Edema Findings Evaluation Form
This form was created by the researcher by scanning the relevant literature to evaluate lymph edema findings. The form will evaluate whether there is swelling, tenderness, pain, stiffness, tension, numbness, burning, tingling, seroma, redness, blistering, warmth and limitation in wrist movements in the affected arm, which may have signs of lymphedema.
Measured: six month
Wound Site Evaluation Form
The Wound Site Evaluation Form was created by the researcher. In the form, the amount, color, density and odor of the exudate, the condition of the wound bed, the temperature of the wound, signs of infection and the duration of the drain are evaluated.
Measured: two month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jan 2024
- Study start15 Mar 2024
- Primary completion30 Oct 2024
- Study completion30 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- two groups with conventional care control groups
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sanko University
- Sponsor type
- University, hospital or other
- Collaborators
- University of Gaziantep
- Responsible party
- Principal investigator, Ebru Karaaslan, Sanko University
- Investigators
- ebru karaaslan, Study director, University of Gaziantep
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06203197
- Sponsor's protocol ID
- SankoU-Nursing-EK-001
- Status last verified
- Aug 2024
- First submitted
- 2 Jan 2024
- Last updated
- 29 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Mobile-Based Care and Monitoring on Lymphatic Edema Management and Quality of Life in Patients Undergoing Breast Surgery
- ClinicalTrials.gov ID
- NCT06203197
- Acronym / sponsor ID
- SankoU-Nursing-EK-001
- Conditions
- Breast Cancer
- Keywords
- breast cancer, post surgical nursing, life quality
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Sanko UniversityUniversity, hospital or other
- Collaborators
- University of Gaziantep
- Study start
- 15 Mar 2024 (actual)
- Primary completion
- 30 Oct 2024 (actual)
- Study completion
- 30 Aug 2025 (actual)
- First posted
- 12 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
There is a lack of synthesized evidence focusing on the design and development of mobile applications targeting the care of patients with breast cancer. This gap will impede understanding of care through mobile applications and hinder digital health intervention strategies that support these patients. Considering the increasing needs of breast cancer patients, the magnitude of care burden, and the widespread use of mobile applications, increased studies are needed to improve care in this population. For this purpose, the mobile application to be developed in the project will include information that patients will need in the perioperative period, preoperative training, exercises to be done in the postoperative period, symptom management, nutrition and lifestyle content. Thus, it is thought that the mobile application will contribute to consultancy and care on issues such as patients' quality of life and symptom management.
Detailed description
Type of study: This study was planned as a randomized controlled intervention study to determine the effect of mobile-based care and monitoring on lymphedema management and quality of life in patients undergoing breast surgery.
Place and time of the research: It will be conducted at SANKO University Hospital General Surgery Service, after obtaining the permission of the ethics committee and the institution.
Research Population and sample of the research: Sample calculation In the doctoral thesis titled "The Effect of Mobile-Based Care Support Application on Symptom Management and Quality of Life of Patients Undergoing Breast Cancer Surgery", taking into account the last measurement quality of life score averages of the patients in the experimental and control groups, alpha = 0.05 and power = 0.80. When the calculation was made, the minimum sample size per group was found to be 18. It is recommended to have a minimum of 30 people per group. Randomization will be done using the minimization method.
Randomization:
- Number of radiotherapy sessions: 25-30
- Area where radiotherapy is applied: breast, lymph nodes, clavicle
- There is / is not lymph node metastasis
- Type of lymph node intervention taken: sentinal, axillary
- Number of lymph nodes removed: 10-20, 21-30, 30 and above
- BMI: 18-30, 30 and above
- Reconstruction plan: yes/no
- Surgery type: breast conservation, lymph node resection.
Application Process:
- Patients who meet the inclusion criteria for the study will be included in the control and intervention groups using the face-to-face interview method. The purpose of the research will be explained to the patients at the first pre-operative meeting in the general surgery service of the mentioned hospital, and an informed consent form and an Introductory Characteristics Questionnaire will be applied. Patients will be evaluated and assigned to groups according to randomization criteria.
Patients in the control group after surgery;
- Wound evaluation form every two weeks in the first two months,
- Monthly Arm Circumference Measurement Form for six months, Lymphatic Edema Findings Evaluation Form
- The Body Image and Sexual Adjustment Scale and Breast Cancer (FACT-B) quality of life scale (FACT-B) will be administered twice, in the first week and at the end of the 6-month period after the surgery.
Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS)) developed within the scope of the research after the surgery.
- Wound evaluation form every two weeks in the first two months,
- Arm Circumference Measurement Form and Lymphatic Discharge Findings Evaluation Form once a month for six months
- The Body Image and Sexual Adjustment Scale and the Functional Assessment Scale in Cancer Treatment (FACT-B) will be administered twice, in the first week and at the end of the 6-month period after the surgery
Since it is thought that the surgeon who performs the surgery is effective in the development of lymphedema, only Prof. Dr. Göktürk Maralcan's patients will be included.
M-MEKKBİS: The content of the application will include a video explaining the use of the application, information about the pre- and post-operative (short and long) period, scales and forms, and ask the specialist sections. Pre-application will be made after the mobile application is ready. A phone number, username and password will be created for patients who will use the mobile application.
Research Inclusion and Exclusion Criteria Acceptance criteria for the study;
- 18 years and over,
- Able to understand and speak Turkish,
- It is decided to undergo breast-conserving surgery or lymph node dissection,
- Using any of the social media applications (facebook, whatsapp, instagram)
Exclusion criteria from the study;
- Having another health problem (amputation, visible scar, visible physical disability, etc.) that may affect body image
- Those with speech, hearing and vision problems
- Having a psychiatric diagnosis
- Having a disease that restricts the movement of the upper extremity (rheumatological diseases, fracture, health problem that will cause joint restriction, amputation, etc.).
- Never used the application
Study termination criteria;
- Discontinuation of communication with the patient before the data collection stages are completed
- Leaving work voluntarily Data collection tools
- Informed Volunteer Consent Form
- Promotional Features Questionnaire
- Wound Site Evaluation Form
- Findings Regarding Lymphatic Edema Evaluation Form
- Body Image and Sexual Adjustment Scale
- Functional Assessment Scale in Cancer Treatment (FACT-B)
- Application Evaluation FormDescriptive Characteristics Questionnaire: This form, prepared by the researcher by scanning the relevant literature, contains 15 questions that will determine the sociodemographic characteristics of the patients and information about the surgery period.
Wound Site Evaluation Form: The Wound Site Evaluation Form was created by the researcher. In the form, the amount, color, density and odor of the exudate, the condition of the wound bed, the temperature of the wound, signs of infection and the duration of the drain are evaluated.
Lymph Edema Findings Evaluation Form: This form was created by the researcher by scanning the relevant literature to evaluate lymph edema findings. The form will evaluate whether there is swelling, tenderness, pain, stiffness, tension, numbness, burning, tingling, seroma, redness, blistering, warmth and limitation in wrist movements in the affected arm, which may have signs of lymphedema.
Body Image and Sexual Adjustment Scale: . The scale, which evaluates sexual adjustment and body image as two separate scales, has 14 items. It can be used as two different scales for women of all ages diagnosed with breast cancer. There is no total score for both scales, and sexual adjustment is evaluated through body image scores. Low mean scores indicate that patients are negatively (badly) affected.
Functional Assessment Scale in Cancer Treatment (FACT-B):
This scale was developed by the "Center on Outcomes, Research, and Education (CORE)" in the USA to determine the quality of life in cancer patients. The Functional Assessment Scale in Cancer Treatment (FACT) has been translated into 52 different languages and has scales for different types of cancer. Functional Assessment in Cancer Treatment-Breast Cancer (FACT-B) quality of life scale is a scale adapted to Turkish by the center that aims to measure the quality of life in breast cancer. Permission to use the scale was received by this center. The scale consists of five sub-dimensions and 36 items. Sub-dimensions; It includes physical (7 items), social/family (7 items), emotional (6 items) and functional well-being (7 items) and breast cancer (9 items). Responses are in five-point Likert type and all item scores are summed as "(0) not at all, (1) very little, (2) a little, (3) quite a bit and (4) very much". In calculating the scale score, negative responses are subtracted from four and included in the scoring, while positive statements are added to the scoring. All of the questions in the physical state sub-dimension and questions 1, 3, 4, 5 and 6 in the emotional state sub-dimension contain negative expressions. The total score of the scale varies between 0-144. The total score of the scale is evaluated in relation to the high quality of life.
Application Evaluation Form: M-MEKKBİS evaluation form was created by the researcher for breast cancer patients to evaluate the application. There are 6 questions in the M-MEKKBİS evaluation form.
Evaluation of data: In the analysis of data, mean ± std is used as descriptive statistics. deviation values will be given. Categorical variables will be defined as number (n) and percentage (%). Student-t test will be used to compare numerical data in 2 groups. Spearman rank correlation coefficient will be used to test the relationships between ordinal variables, and Chi square test and Fisher's exact Chi square test will be used to test the relationships between categorical variables. Analyzes will be performed in the Statistical Package for the Social Sciences (SPSS) 25.0 package program.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- two groups with conventional care control groups
| Arm | Type | Receives |
|---|---|---|
| control | No intervention | –Patients in the control group will receive routine clinical care after surgery. |
| intervention | Experimental | Other: Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS)Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS)) developed within the scope of the research after the surgery. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- 18 years and over,
- Able to understand and speak Turkish,
- It is decided to undergo breast-conserving surgery or lymph node dissection,
- Using any of the social media applications (facebook, whatsapp, instagram)
Key exclusion criteria (8 listed)
- Having another health problem (amputation, visible scar, visible physical disability, etc.) that may affect body image
- Those with speech, hearing and vision problems
- Having a psychiatric diagnosis
- Having a disease that restricts the movement of the upper extremity (rheumatological diseases, fracture, health problem that will cause joint restriction, amputation, etc.).
- Never used the application
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS)intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS). | Other | intervention |
Primary outcome
Functional Assessment Scale in Cancer Treatment (FACT-B):
Time frame: six month
This scale was developed by the "Center on Outcomes, Research, and Education (CORE)" in the USA to determine the quality of life in cancer patients. The Functional Assessment Scale in Cancer Treatment (FACT) has been translated into 52 different languages and has scales for different types of cancer. Functional Assessment in Cancer Treatment-Breast Cancer (FACT-B) quality of life scale is a scale adapted to Turkish by the center that aims to measure the quality of life in breast cancer. Permission to use the scale was received by this center . All of the questions in the physical state sub-dimension and questions 1, 3, 4, 5 and 6 in the emotional state sub-dimension contain negative expressions. The total score of the scale varies between 0-144. The total score of the scale is evaluated in relation to the high quality of life.
3 secondary outcomes
Body Image and Sexual Adjustment Scale
Time frame: six month
Lymph Edema Findings Evaluation Form
Time frame: six month
Wound Site Evaluation Form
Time frame: two month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Breast Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
ebru karaaslan study director
University of Gaziantep
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Patients in the intervention group will use the mobile-based care support application (M-Breast cancer personal care and monitoring system (M-MEKKBİS) in people with Breast Cancer, run by Sanko University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Functional Assessment Scale in Cancer Treatment (FACT-B): (time frame: six month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2026.